PRINCETON, N.J. & DEERFIELD, Ill.–(BUSINESS WIRE)–Otsuka America Pharmaceutical, Inc. (Otsuka) and Lundbeck announce the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ABILIFY ASIMTUFII® (aripiprazole) extended-release injectable suspension for intramuscular use, a once-every-two-months injection for the treatment of schizophrenia in adults or for maintenance monotherapy treatment of bipolar I … [Read more…]

VIENNA, Va.–(BUSINESS WIRE)–$CVM–CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced the pricing of its underwritten confidentially marketed public offering of 794,117 shares of common stock at an offering price of $1.70 per share. The closing of the offering is expected to take place on or about … [Read more…]

New transitional housing facility made possible through a $500,000 grant from Amerigroup COLUMBUS, Ga.–(BUSINESS WIRE)–Micah’s Promise, a non-profit organization that educates the public about prevention of youth sex trafficking and intervention and support for victims, unveiled its newest facility for young women at an event Thursday. Amerigroup donated $500,000 to help complete the second phase … [Read more…]

Fresh capital for funding Phase IIb and Phase III trials, expands growth, and fuels shareholder value DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announces the execution of a letter of intent to sale the Cardinal Milestone Payment … [Read more…]

Palone will utilize pharmaceutical expertise to grow Medication Management division BROOMFIELD, Colo.–(BUSINESS WIRE)–Swisslog Healthcare, a leading supplier in medication management and transport automation solutions, has promoted Michael Palone to Vice President of Product Management for the Medication Management division. In his new role, Palone will lead a new team that includes Product Managers, Business Analysts, … [Read more…]

CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported strong operational performance driven by Aptar’s Pharma and Beauty segments. Reported sales increased by 2% and core sales, excluding currency and acquisition effects, increased 4%. Aptar reported net income of $55 … [Read more…]

EMERYVILLE, Calif.–(BUSINESS WIRE)–$NBY #Avenova–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announced today that it has entered into a securities purchase agreement with institutional accredited investors (“Purchasers”) in connection with a private placement to issue secured senior convertible debentures (the “Debentures”) and two series of new warrants exercisable for NovaBay common stock (the … [Read more…]

EXETER, N.H.–(BUSINESS WIRE)–Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), today announced that it will release financial results for the first quarter of 2023 after the close of trading on Wednesday, May 3, 2023. Vapotherm’s management team will host a conference call beginning at 4:30 p.m. ET to discuss the financial results and recent business … [Read more…]

Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich.–(BUSINESS WIRE)–InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue first quarter 2023 financial results on Thursday, May … [Read more…]

NEW YORK–(BUSINESS WIRE)–MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced the closing of its previously announced public offering of 2,555,500 shares of its common stock at a public offering price of $2.25 per share, for gross proceeds of approximately $5.75 million, before deducting underwriting discounts and … [Read more…]